We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LITB:NYSELightInTheBox Holding Co., Ltd. Analysis

Data as of 2026-04-15 - not real-time

$2.38

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

LightInTheBox is trading at $2.38, comfortably above its 20‑day SMA of 2.27 but still below the 50‑day SMA of 2.49, indicating a short‑term bias that leans slightly bullish. The MACD histogram is positive and the signal line turned bullish, while the RSI sits near the midpoint at 52, suggesting limited overbought pressure. The stock sits near its technical support of 1.85 and well below the resistance level of 2.72, offering a modest upside cushion. Fundamentally, the company posted a 9% year‑over‑year revenue increase to $224 M, maintained a strong gross margin of 65% and turned a record full‑year profit of $8.3 M, marking the seventh consecutive profitable quarter. Valuation metrics are compelling: a trailing PE of 4.96 versus a forward PE of 119 reflects a steep earnings decline outlook, yet the DCF‑derived fair value of $4.52 suggests the market is substantially undervaluing the stock. Cash generation remains solid with operating cash flow of $6.2 M and free cash flow of $3.25 M, while debt is minimal and equity is negative, underscoring a precarious balance sheet. However, the stock exhibits high 30‑day volatility at 78% and a historical max drawdown of -55%, paired with decreasing volume and a modest market cap of $43.5 M, which amplifies liquidity concerns. Overall, the combination of a strong earnings streak, attractive valuation gaps, and modest technical bullishness points to upside potential, but the elevated volatility and liquidity constraints warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD and RSI near neutral
  • Price near technical support with limited upside
  • High short‑term volatility and low trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Record profitability and 9% revenue growth
  • Undervalued relative to DCF fair value
  • Strong gross margins and positive cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained profit streak and expanding international presence
  • Low leverage and ample cash reserves
  • Significant upside potential as market re‑prices the low PE and DCF gap

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin3.69%
P/E Ratio5.0
ROA7.71%
P/B Ratio-10.8
Op. Cash Flow$6.2M
Free Cash Flow$3.3M

Technical Analysis

TrendNeutral
RSI52.0
Support$1.85
Resistance$2.72
MA 20$2.27
MA 50$2.49
MA 200$2.12
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64

Valuation

Fair Value$4.52
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.22
Volatility78.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.